CARTHRONIX, INC.
Tarzana, CA · Biotech · Private
Small molecule gp130 signaling modulators to prevent fibroblast differentiation and reduce excessive collagen deposition in joint fibrosis
- Grants
- $234K
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 10
- 0 granted · 10 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Advancement of a lead small molecule gp130 modulator for improving outcomes in joint fibrosis | $233,700 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1766 | Akeso Biomedical, Inc. | — | $2.1M |
| 1767 | SegueTX-Pancreatic Cancer, L.L.C. | — | — |
| 1768 | Abfero Pharmaceuticals, Inc. | — | $1.5M |
| 1769 | CARTHRONIX, INC. | — | — |
| 1770 | OPSIDIO, LLC | — | $800K |
| 1771 | Bedrocan Internatioinal, Inc. | — | $200K |
| 1772 | Deep Longevity | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Small Molecule Modulators Of GP130 Signaling Pathwaysapplication
- Small Molecule Modulators Of GP130 Signaling Pathways, Topical Formulations And Method Of Use Thereofapplication
- Compositions And Methods For Modulating GP130 Activityapplication
- Small Molecule Modulators Of GP130 Signaling Pathwaysapplication
- Small Molecule Modulators Of GP130 Signaling Pathwaysapplication
- Small Molecule Modulators Of GP130 Signaling Pathways, Topical Formulations And Method Of US Thereofapplication
- TOPICAL FORMULATION OF gp130 SIGNALING PATHWAY MODULATORSapplication
- Small Molecule Modulators Of GP130 Signaling Pathways, And Method Of Use Thereofapplication
- Compositions And Methods For Modulating GP130 Activityapplication
- Compositions And Methods For Modulating GP130 Activityapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.